Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Bhattacharya faces Senate grilling on NIH disruptions
“In total, the NIH has terminated or frozen at least $561 million in research and defunded more than 300 clinical trials ...,” Bernie Sanders said.
Gabrielle Masson
Feb 3, 2026 5:20pm
HHS launches $100M prize to develop antiviral therapies
Feb 3, 2026 4:00pm
Sponsored
Inside Henlius’ global growth strategy
Feb 2, 2026 8:00am
Charles River to close Maryland CDMO site, lay off 20 staffers
Feb 3, 2026 12:20pm
FDA to ‘carefully shepherd’ CAR-T for autoimmune disease: Prasad
Feb 3, 2026 11:40am
Exxel plans $13M IPO to score where other FAAH inhibitors failed
Feb 3, 2026 11:33am
More News
Bourla says pipeline pruning is mostly done after 6 more culls
Feb 3, 2026 11:33am
Pfizer links monthly GLP-1 to competitive weight loss in phase 2
Feb 3, 2026 8:45am
NMD accelerates rare disease asset despite primary endpoint miss
Feb 3, 2026 4:30am
Novo’s CagriSema tops semaglutide in ph. 3 diabetes study
Feb 2, 2026 3:01pm
See more stories